In This Article: FARMINGDALE, N.Y. (AP) - FARMINGDALE, N.Y. (AP) - Enzo Biochem Inc. (ENZ) on Monday reported a loss of $1.5 million in its fiscal second quarter. The Farmingdale, New York-based company said it had a loss of 3 cents per share. Losses, adjusted to account for discontinued operations and non-recurring costs, were 2 cents per share. The life sciences and biotechnology company posted revenue of $7.3 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ENZ at https://www.zacks.com/ap/ENZ
Enzo is a New York-based biotechnology company that develops diagnostics tests for the treatment of cancer, diabetes, HIV, uveitis, and inflammatory bowel diseases.